Iyeon Rasagiline Mesylate Tablet
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Iyeon Pharmaceutical Co., Ltd.
MFDS item code 201907650 · Approved 2019.10.31
This product's status changed to Approval withdrawn on 2024.02.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson's disease
This medicine is used to treat idiopathic Parkinson's disease. Initially, it is administered alone or in combination with dopamine agonists to alleviate symptoms. It also helps improve symptoms when motor abilities decline, especially during 'end of dose fluctuations' when the effect of the medication decreases, by being used in conjunction with levodopa. This is utilized to effectively manage motor impairments in Parkinson's disease patients.
This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medication should not be used by patients with allergies to the active ingredient or other components of this medicine. Patients currently taking or who have stopped taking other MAO inhibitors within the last 2 weeks should not use this medication. Patients taking certain medications such as pethidine, tramadol, or dextromethorphan should be cautious, as serious side effects may occur if this drug is administered. Patients with moderate to severe liver function impairment should not use this medication, and those with mild liver impairment should take it with caution. While taking this medicine, various side effects such as headaches, dizziness, nausea, insomnia, musculoskeletal pain, and dermatitis may occur. Additionally, psychiatric and neurological symptoms such as hallucinations, depression, movement disorders, increased blood pressure, hypotension, and impulse control disorders may appear, requiring careful monitoring. Particularly, this drug may affect driving or machine operation ability, so patients experiencing drowsiness or sudden sleep events should avoid such activities. This medication can interact severely with other MAO inhibitors, specific analgesics, antidepressants, and sympathomimetics, so it must be discussed with a doctor or pharmacist. Women who are pregnant or breastfeeding should use this medication with caution, and the safety for pediatric use has not been confirmed. In cases of overdose, severe symptoms such as hypertensive crisis or serotonin syndrome may occur, necessitating immediate medical attention if overdose is suspected. Store this medication out of the reach of children, in a well-sealed container away from air and moisture, and at appropriate temperatures (1-25 degrees). Avoid transferring to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. The appropriate storage temperature is in a cool place between 1 and 25 degrees.
White round tablet
30 tablets/PTP [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Iyeon Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.